🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT00869817
Recruiting Observational

Dominantly Inherited Alzheimer Network (DIAN)

NCT00869817 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2009-01
Last updated
2026-09-25

Condition(s) studied

Alzheimer's Disease

Study summary

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Written informed consent obtained from participant and collateral source prior to any study-related procedures. * Aged 18 (inclusive) or older and the child of an affected individual (clinically or by testing) in a pedigree with a known mutation for ADAD. * Cognitively normal to very mild or mild cognitive impairment (CDR score range 0-1.0). Primary enrollment will focus on the recruitment of asymptomatic adult children who are more than 15 years younger than the estimated age of symptom onset. Enrollment of new participants with moderate cognitive impairment is allowed with the prior approval of the DIAN Coordinating Center. * Has two persons who are not their full-blooded siblings who can serve as collateral sources for the study. * Fluent in a language approved by the DIAN Coordinating Center at about the 6th grade level (international equivalent) or above. Exclusion Criteria: * Under age 18 * Medical or psychiatric illness that would interfere in completing initial and follow-up visits * Requires nursing home level care * Has no one who can serve as a study informant

Primary outcome measure(s)

Trial sites (26)

FacilityCityRegionStatus
Mayo Clinic Jacksonville Jacksonville Florida Recruiting
Indiana University-Indiana Alzheimer Disease Center Indianapolis Indiana Recruiting
Brigham and Women's Hospital Boston Massachusetts Recruiting
Washington University in St. Louis School of Medicine St Louis Missouri Recruiting
Columbia University New York New York Suspended
University of Pittsburgh Pittsburgh Pennsylvania Recruiting
Butler Hospital Providence Rhode Island Recruiting
University of Washington Seattle Washington Recruiting
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) Salta Salta Province Recruiting
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa Buenos Aires Argentina Recruiting
Neuroscience Research Australia Sydney New South Wales Recruiting
Mental Health Research Institute, University of Melbourne Melbourne Victoria Suspended
Sir James McCusker Alzheimer's Disease Research Unit, Edith Cowan University Perth Western Australia Recruiting
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo São Paulo Recruiting
McGill University Research Centre for Studies in Aging Verdun Quebec Not Yet Recruiting
Grupo Neurociencias de Antioquia Medellín Colombia Recruiting
German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich Munich Germany Recruiting
German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen Tübingen Germany Recruiting
Niigata University Niigata Japan Recruiting
Osaka City University Osaka Japan Suspended
Tokyo University Tokyo Japan Recruiting
Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez" Mexico City Mexico City Recruiting
Amsterdam UMC Amsterdam Netherlands Recruiting
Asan Medical Center Seoul Songpa-Gu Recruiting
Hospital Clinic Barcelona Barcelona Catalonia Suspended
Institute of Neurology, Queen Square London United Kingdom Recruiting

More Washington University School of Medicine trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00869817 on ClinicalTrials.gov ↗ ← All trials in Germany